Gleason pattern 4 or 5 found at a positive surgical margin following robot-assisted radical prostatectomy predicts early biochemical recurrence.
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
In a study, all men who received testosterone replacement therapy within 1 year of robot-assisted radical prostatectomy had full potency recovery at 24 months.
Testosterone replacement therapy prolonged time to disease progression among men who underwent radical surgery for localized prostate cancer.
Improved visualization of prostatic arteries shortens procedure time and decreases radiation exposure, new findings suggest.
A phase 2 study demonstrated higher rates of pathologic complete response or minimal residual disease.
A population-based study found no effect of low-dose aspirin use within 1 year of diagnosis on prostate cancer death risk.
Investigators using a bone-seeking radiopharmaceutical show for the first time that atherosclerosis in penile arteries is associated with an increased risk of erectile dysfunction.
Time from definitive therapy for localized prostate cancer to the start of androgen deprivation therapy (ADT) independently predicts the risk of metastatic castration-resistant prostate cancer (mCRPC) and death, a new study suggests. The study, led by Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah in Salt Lake City, included 253…
Almost one quarter of men who have a single negative prostate biopsy are eventually diagnosed with prostate cancer (PCa) within 20 years, according to investigators. The finding is from a study of 95,675 men who had a negative first transrectal ultrasound (TRUS)-guided prostate biopsy from January 1994 to October 2014. The 5-, 10-, 15, and…